713(top 0.1%)
PR articles
175.3K(top 0.1%)
PR citations
137(top 0.1%)
PR h-index
148(top 0.1%)
h-index
853
documents
223.0K
doc citations
12.8K
citing journals
100
times ranked

Publications

732 peer-reviewed articles • 204,656 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1The Contribution of Noncommunicable and Infectious Diseases to the Effect of Depression on Mortality: A Longitudinal Causal Mediation Analysis
Epidemiology, 2025, 36, 88-98
2.87Citations (PDF)
2Late Re-Engagement Into HIV Care Among Adults in the Swiss HIV Cohort Study1.81Citations (PDF)
3Patterns of incident Burkitt lymphoma during the HIV epidemic among the Black African and White population in South Africa
British Journal of Cancer, 2025, 132, 462-468
5.53Citations (PDF)
4Estimating Mycobacterium tuberculosis transmission in a South African clinic: Spatiotemporal model based on person movements
PLoS Computational Biology, 2025, 21, e1012823
3.14Citations (PDF)
5Infection prevention and control measures during the COVID-19 pandemic and airborne tuberculosis transmission during primary care visits in South Africa2.14Citations (PDF)
6Cervical precancer and cancer incidence among insured women with and without HIV in South Africa4.37Citations (PDF)
7Airborne transmission risks of tuberculosis and COVID-19 in schools in South Africa, Switzerland, and Tanzania: Modeling of environmental data
PLOS Global Public Health, 2024, 4, e0002800
2.16Citations (PDF)
8Area-level excess mortality in times of COVID-19 in Switzerland: geographical, socioeconomic and political determinants0.31Citations (PDF)
9Body weight and blood pressure changes on dolutegravir‐, efavirenz‐ or atazanavir‐based antiretroviral therapy in Zimbabwe: a longitudinal study3.419Citations (PDF)
10Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal study
PLoS ONE, 2024, 19, e0293162
2.31Citations (PDF)
11Molecular detection of SARS-CoV-2 and other respiratory viruses in saliva and classroom air: a two winters tale
Clinical Microbiology and Infection, 2024, 30, 829.e1-829.e4
5.311Citations (PDF)
12Combining randomized and non‐randomized data to predict heterogeneous effects of competing treatments
Research Synthesis Methods, 2024, 15, 641-656
4.86Citations (PDF)
13Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study1.14Citations (PDF)
14Cancer diagnostic service use in people living with HIV in South Africa: A cross-sectional study
PLoS ONE, 2024, 19, e0291897
2.32Citations (PDF)
15Protocol for the development of a reporting guideline for umbrella reviews on epidemiological associations using cross-sectional, case-control and cohort studies: the Preferred Reporting Items for Umbrella Reviews of Cross-sectional, Case-control and Cohort studies (PRIUR-CCC)
BMJ Open, 2024, 14, e071136
1.94Citations (PDF)
16Virologic Failure and Drug Resistance After Programmatic Switching to Dolutegravir-based First-line Antiretroviral Therapy in Malawi and Zambia
Clinical Infectious Diseases, 2024, 80, 120-128
5.217Citations (PDF)
17HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST)
BMJ Open, 2024, 14, e085819
1.97Citations (PDF)
18Courier delivery of antiretroviral therapy: a cohort study of a South African private‐sector HIV programme3.40Citations (PDF)
19Alpha Variant Coronavirus Outbreak in a Nursing Home Despite High Vaccination Coverage: Molecular, Epidemiological, and Immunological Studies
Clinical Infectious Diseases, 2023, 77, 537-546
5.27Citations (PDF)
20Age and Cancer Incidence in 5.2 Million People With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study
Clinical Infectious Diseases, 2023, 76, 1440-1448
5.218Citations (PDF)
21Direct and indirect effects of the COVID-19 pandemic on mortality in Switzerland13.732Citations (PDF)
22Decreasing incidence of conjunctival squamous cell carcinoma in people with HIV in South Africa4.64Citations (PDF)
23SARS-CoV-2 transmission with and without mask wearing or air cleaners in schools in Switzerland: A modeling study of epidemiological, environmental, and molecular data
PLoS Medicine, 2023, 20, e1004226
8.027Citations (PDF)
24Relationship between journal impact factor and the thoroughness and helpfulness of peer reviews
PLoS Biology, 2023, 21, e3002238
5.036Citations (PDF)
25Development of the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guideline
BMJ Open, 2023, 13, e074626
1.950Citations (PDF)
26Tracing People Living With Human Immunodeficiency Virus Who Are Lost to Follow-up at Antiretroviral Therapy Programs in Southern Africa: A Sampling-Based Cohort Study in 6 Countries
Clinical Infectious Diseases, 2022, 74, 171-179
5.216Citations (PDF)
27Introducing the Treatment Hierarchy Question in Network Meta-Analysis3.393Citations (PDF)
28Estimating Tuberculosis Transmission Risks in a Primary Care Clinic in South Africa: Modeling of Environmental and Clinical Data
Journal of Infectious Diseases, 2022, 225, 1642-1652
3.714Citations (PDF)
29Regional excess mortality during the 2020 COVID-19 pandemic in five European countries13.7113Citations (PDF)
30Cervical Cancer Screening Cascade for women living with HIV: A cohort study from Zimbabwe
PLOS Global Public Health, 2022, 2, e0000156
2.120Citations (PDF)
31Screening for hepatocellular carcinoma among adults with HIV/HBV co-infection in Zambia: a pilot study2.19Citations (PDF)
32Cancer incidence among people living with HIV in Zimbabwe: A record linkage study
Cancer Reports, 2022, 5,
1.74Citations (PDF)
33Acquired HIV drug resistance mutations on first-line antiretroviral therapy in Southern Africa: Systematic review and Bayesian evidence synthesis3.728Citations (PDF)
34Integrating services for HIV and multidrug-resistant tuberculosis: A global cross-sectional survey among ART clinics in low- and middle-income countries
PLOS Global Public Health, 2022, 2, e0000180
2.17Citations (PDF)
35Cohort profile: the South African HIV Cancer Match (SAM) Study, a national population-based cohort
BMJ Open, 2022, 12, e053460
1.915Citations (PDF)
36Combining individual patient data from randomized and non-randomized studies to predict real-world effectiveness of interventions1.67Citations (PDF)
37Survival among people hospitalized with COVID-19 in Switzerland: a nationwide population-based analysis
BMC Medicine, 2022, 20,
7.115Citations (PDF)
38Is Internal Rotation Measurement of the Hip Useful for Ruling in Cam or Pincer Morphology in Asymptomatic Males? A Diagnostic Accuracy Study1.71Citations (PDF)
39Rethinking the Funding Line at the Swiss National Science Foundation: Bayesian Ranking and Lottery1.619Citations (PDF)
40HIV suppression was maintained during the COVID-19 pandemic in Malawi: a program-level cohort study3.718Citations (PDF)
41Liver steatosis and metabolic dysfunction-associated fatty liver disease among HIV-positive and negative adults in urban Zambia
BMJ Open Gastroenterology, 2022, 9, e000945
2.311Citations (PDF)
42Availability and experiences of differentiated antiretroviral therapy delivery at HIV care facilities in rural Zimbabwe: a mixed‐method study3.412Citations (PDF)
43Public preferences towards data management and governance in Swiss biobanks: results from a nationwide survey
BMJ Open, 2022, 12, e060844
1.99Citations (PDF)
44Cancer treatment and survival among cervical cancer patients living with or without HIV in South Africa0.77Citations (PDF)
45Mathematical Models for Evaluating Effectiveness and Cost-Effectiveness of Cervical Cancer Control Policies in Populations Including Women Living With Human Immunodeficiency Virus: A Scoping Review1.37Citations (PDF)
46Diagnosis and treatment of opioid-related disorders in a South African private sector medical insurance scheme: A cohort study3.311Citations (PDF)
47The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population
Annals of Internal Medicine, 2022, 175, 1560-1571
9.6166Citations (PDF)
48Impact of the COVID‐19 pandemic on TB services at ART programmes in low‐ and middle‐income countries: a multi‐cohort survey3.418Citations (PDF)
49Metabolic syndrome among treatment‐naïve people living with and without HIV in Zambia and Zimbabwe: a cross‐sectional analysis3.418Citations (PDF)
50Investigating and dealing with publication bias and other reporting biases in meta‐analyses of health research: A review
Research Synthesis Methods, 2021, 12, 248-259
4.8231Citations (PDF)
51Meta‐analysis as a system of springs4.81Citations (PDF)
52A Bayesian dose–response meta-analysis model: A simulations study and application1.641Citations (PDF)
53Losing ground at the wrong time: trends in self-reported influenza vaccination uptake in Switzerland, Swiss Health Survey 2007–2017
BMJ Open, 2021, 11, e041354
1.914Citations (PDF)
54Part-time work and other occupational risk factors for suicide among working women in the Swiss National Cohort2.09Citations (PDF)
55Immunodeficiency and Cancer in 3.5 Million People Living With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study
Clinical Infectious Diseases, 2021, 73, e735-e744
5.232Citations (PDF)
56Identification of socio‐demographic, occupational, and societal factors for guiding suicide prevention: A cohort study of Swiss male workers (2000–2014)2.29Citations (PDF)
57Effects of National Adoption of Treat-All Guidelines on Pre-Antiretroviral Therapy (ART) CD4 Testing and Viral Load Monitoring After ART initiation: A Regression Discontinuity Analysis
Clinical Infectious Diseases, 2021, 73, e1273-e1281
5.226Citations (PDF)
58Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study
Lancet Microbe, The, 2021, 2, e320-e330
12.341Citations (PDF)
59Public willingness to participate in personalized health research and biobanking: A large-scale Swiss survey
PLoS ONE, 2021, 16, e0249141
2.356Citations (PDF)
60Face-to-face panel meetings versus remote evaluation of fellowship applications: simulation study at the Swiss National Science Foundation
BMJ Open, 2021, 11, e047386
1.99Citations (PDF)
61A two‐stage prediction model for heterogeneous effects of treatments
Statistics in Medicine, 2021, 40, 4362-4375
1.727Citations (PDF)
62No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL3.417Citations (PDF)
63Treatment outcomes in HIV infected patients older than 50 years attending an HIV clinic in Harare, Zimbabwe: A cohort study
PLoS ONE, 2021, 16, e0253000
2.313Citations (PDF)
64Characteristics of scholars who review for predatory and legitimate journals: linkage study of Cabells Scholarly Analytics and Publons data
BMJ Open, 2021, 11, e050270
1.922Citations (PDF)
65Symptoms of common mental disorders and adherence to antiretroviral therapy among adults living with HIV in rural Zimbabwe: a cross-sectional study
BMJ Open, 2021, 11, e049824
1.911Citations (PDF)
66Use and caregiver-reported efficacy of medical cannabis in children and adolescents in Switzerland
European Journal of Pediatrics, 2021, 181, 335-347
2.113Citations (PDF)
67The HIV care cascade in sub‐Saharan Africa: systematic review of published criteria and definitions3.429Citations (PDF)
68Quantifying Floating Plastic Debris at Sea Using Vessel-Based Optical Data and Artificial Intelligence
Remote Sensing, 2021, 13, 3401
3.747Citations (PDF)
69Socioeconomic position and the COVID-19 care cascade from testing to mortality in Switzerland: a population-based analysis
Lancet Public Health, The, 2021, 6, e683-e691
18.7135Citations (PDF)
70Regression discontinuity analysis demonstrated varied effect of Treat-All on CD4 testing among Southern African countries3.712Citations (PDF)
71Cancer risk in adolescents and young adults living with HIV in South Africa: a nationwide cohort study
Lancet HIV,the, 2021, 8, e614-e622
7.917Citations (PDF)
72External background ionizing radiation and childhood cancer: Update of a nationwide cohort analysis2.016Citations (PDF)
73Comparing methods for estimating patient‐specific treatment effects in individual patient data meta‐analysis
Statistics in Medicine, 2021, 40, 1553-1573
1.729Citations (PDF)
74Drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) in nine southern African countries: a modelling study2.615Citations (PDF)
75Cancer in HIV-positive and HIV-negative adolescents and young adults in South Africa: a cross-sectional study
BMJ Open, 2021, 11, e043941
1.911Citations (PDF)
76Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization16.53,625Citations (PDF)
77Development, validation and clinical usefulness of a prognostic model for relapse in relapsing-remitting multiple sclerosis2.410Citations (PDF)
78Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries
Lancet HIV,the, 2021, 8, e766-e775
7.9106Citations (PDF)
79Cervical cancer risk in women living with HIV across four continents: A multicohort study4.363Citations (PDF)
80Construct validity of the Physiotherapy Evidence Database (PEDro) quality scale for randomized trials: Item response theory and factor analyses
Research Synthesis Methods, 2020, 11, 227-236
4.872Citations (PDF)
81Microbial community composition and functional potential in Bothnian Sea sediments is linked to Fe and S dynamics and the quality of organic matter3.747Citations (PDF)
82Optimal Dose of Selective Serotonin Reuptake Inhibitors, Venlafaxine, and Mirtazapine in Major Depression: A Systematic Review and Dose-Response Meta-Analysis1.111Citations (PDF)
83HIV Coinfection Is Associated with Low-Fitness rpoB Variants in Rifampicin-Resistant Mycobacterium tuberculosis4.113Citations (PDF)
84Widespread energy limitation to life in global subseafloor sediments
Science Advances, 2020, 6,
10.9108Citations (PDF)
85Trends in CD4 and viral load testing 2005 to 2018: multi‐cohort study of people living with HIV in Southern Africa3.446Citations (PDF)
86Loss to follow-up correction increased mortality estimates in HIV–positive people on antiretroviral therapy in Mozambique3.722Citations (PDF)
87Gender and other potential biases in peer review: cross-sectional analysis of 38 250 external peer review reports
BMJ Open, 2020, 10, e035058
1.944Citations (PDF)
88Novel approach to estimate tuberculosis transmission in primary care clinics in sub-Saharan Africa: protocol of a prospective study
BMJ Open, 2020, 10, e036214
1.95Citations (PDF)
89Agreement between ranking metrics in network meta-analysis: an empirical study
BMJ Open, 2020, 10, e037744
1.926Citations (PDF)
90Mental health, substance use and viral suppression in adolescents receiving ART at a paediatric HIV clinic in South Africa3.467Citations (PDF)
91First evidence of plastic fallout from the North Pacific Garbage Patch
Scientific Reports, 2020, 10,
3.4168Citations (PDF)
92Effect of postoperative continuation of antibiotic prophylaxis on the incidence of surgical site infection: a systematic review and meta-analysis
Lancet Infectious Diseases, The, 2020, 20, 1182-1192
16.5127Citations (PDF)
93International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012–2019
BMJ Open, 2020, 10, e035246
1.9100Citations (PDF)
94CINeMA: An approach for assessing confidence in the results of a network meta-analysis
PLoS Medicine, 2020, 17, e1003082
8.01,495Citations (PDF)
95CINeMA: Software for semiautomated assessment of the confidence in the results of network meta‐analysis12.0468Citations (PDF)
96In network meta-analysis, most of the information comes from indirect evidence: empirical study3.746Citations (PDF)
97A spatially variable scarcity of floating microplastics in the eastern North Pacific Ocean4.955Citations (PDF)
98Discipline-specific open access publishing practices and barriers to change: an evidence-based review
F1000Research, 2020, 7, 1925
0.564Citations (PDF)
99Journal- or article-based citation measure? A study of academic promotion at a Swiss university
F1000Research, 2020, 9, 1188
0.57Citations (PDF)
100Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL’HIV trial
PLoS Medicine, 2020, 17, e1003421
8.031Citations (PDF)
101Universal health coverage financing in South Africa: wishes vs reality0.418Citations (PDF)
102Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study
PLoS Medicine, 2020, 17, e1003397
8.018Citations (PDF)
103Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South Africa
PLoS Computational Biology, 2019, 15, e1007083
3.115Citations (PDF)
104Long-term retention on antiretroviral therapy among infants, children, adolescents and adults in Malawi: A cohort study
PLoS ONE, 2019, 14, e0224837
2.326Citations (PDF)
105Similar Allergenicity to Different Artemisia Species Is a Consequence of Highly Cross-Reactive Art v 1-Like Molecules
Medicina (Lithuania), 2019, 55, 504
2.021Citations (PDF)
106Virologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysis
F1000Research, 2019, 7, 1359
0.525Citations (PDF)
107A global mass budget for positively buoyant macroplastic debris in the ocean3.4473Citations (PDF)
108Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis4.180Citations (PDF)
109Blacklists and Whitelists To Tackle Predatory Publishing: a Cross-Sectional Comparison and Thematic Analysis
MBio, 2019, 10,
4.4107Citations (PDF)
110Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis
Lancet Psychiatry,the, 2019, 6, 601-609
17.3302Citations (PDF)
111Controls on volatile fatty acid concentrations in marine sediments (Baltic Sea)4.852Citations (PDF)
112Synthesizing existing evidence to design future trials: survey of methodologists from European institutions
Trials, 2019, 20,
2.09Citations (PDF)
113The burden of cancers associated with HIV in the South African public health sector, 2004–2014: a record linkage study2.563Citations (PDF)
114Network meta‐analysis of rare events using the Mantel‐Haenszel method
Statistics in Medicine, 2019, 38, 2992-3012
1.793Citations (PDF)
115Pulmonary arterial pressure at rest and during exercise in chronic mountain sickness: a meta-analysis
European Respiratory Journal, 2019, 53, 1802040
8.729Citations (PDF)
116Organoclastic sulfate reduction in the sulfate-methane transition of marine sediments4.884Citations (PDF)
117Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Lancet, The, 2019, 393, 1948-1957
62.12,404Citations (PDF)
118Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV‐positive individuals
Statistics in Medicine, 2019, 38, 2428-2446
1.721Citations (PDF)
119COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology
PLoS Medicine, 2019, 16, e1002742
8.0450Citations (PDF)
120Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study16.559Citations (PDF)
121Spatial epidemiology of gestational age and birth weight in Switzerland: census-based linkage study
BMJ Open, 2019, 9, e027834
1.912Citations (PDF)
122Extending Visit Intervals for Clinically Stable Patients on Antiretroviral Therapy: Multicohort Analysis of HIV Programs in Southern Africa1.84Citations (PDF)
123Impact of natural re-oxygenation on the sediment dynamics of manganese, iron and phosphorus in a euxinic Baltic Sea basin4.857Citations (PDF)
124Challenges in assessing the sunscreen‐melanoma association
International Journal of Cancer, 2019, 144, 2651-2668
4.337Citations (PDF)
125Effectiveness of 80% vs 30–35% fraction of inspired oxygen in patients undergoing surgery: an updated systematic review and meta-analysis
British Journal of Anaesthesia, 2019, 122, 325-334
4.994Citations (PDF)
126Prevalence of sleep-disordered breathing after stroke and TIA
Neurology, 2019, 92,
1.0213Citations (PDF)
127The use of mathematical modeling studies for evidence synthesis and guideline development: A glossary
Research Synthesis Methods, 2019, 10, 125-133
4.859Citations (PDF)
128A model for meta-analysis of correlated binary outcomes: The case of split-body interventions1.610Citations (PDF)
129Data management of clinical trials during an outbreak of Ebola virus disease
Vaccine, 2019, 37, 7183-7189
3.16Citations (PDF)
130Safety of 80% vs 30–35% fraction of inspired oxygen in patients undergoing surgery: a systematic review and meta-analysis
British Journal of Anaesthesia, 2019, 122, 311-324
4.996Citations (PDF)
131Non-AIDS defining malignancies in the combination ART era: immunological and socio-behavioral risk factors
F1000Research, 2019, 8, 1400
0.51Citations (PDF)
132Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
Lancet, The, 2018, 391, 1357-1366
62.13,097Citations (PDF)
133Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs
Clinical Infectious Diseases, 2018, 66, 893-903
5.2118Citations (PDF)
134Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomized trials with registries
Rheumatology, 2018, 57, 354-369
1.961Citations (PDF)
135Methane Feedbacks to the Global Climate System in a Warmer World
Reviews of Geophysics, 2018, 56, 207-250
34.2550Citations (PDF)
136HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe0.839Citations (PDF)
137Seasonal variations in tuberculosis diagnosis among HIV-positive individuals in Southern Africa: analysis of cohort studies at antiretroviral treatment programmes
BMJ Open, 2018, 8, e017405
1.97Citations (PDF)
138Neglect of attention to reproductive health in women with HIV infection: contraceptive use and unintended pregnancies in the Swiss HIV Cohort Study
HIV Medicine, 2018, 19, 339-346
2.814Citations (PDF)
139Death at no cost? Persons with no health insurance claims in the last year of life in Switzerland2.51Citations (PDF)
1400464 Prevalence Of Sleep-disordered Breathing After Stroke And Transitory Ischemic Attack: A Meta-analysis
Sleep, 2018, 41, A175-A176
0.91Citations (PDF)
141Occupational extremely low frequency magnetic fields (ELF-MF) exposure and hematolymphopoietic cancers – Swiss National Cohort analysis and updated meta-analysis
Environmental Research, 2018, 164, 467-474
7.729Citations (PDF)
142CPAP as treatment of sleep apnea after stroke
Neurology, 2018, 90,
1.096Citations (PDF)
143Continuously updated network meta-analysis and statistical monitoring for timely decision-making1.638Citations (PDF)
144World Health Organization Responds to Concerns about Surgical Site Infection Prevention Recommendations
Anesthesiology, 2018, 128, 221-222
2.29Citations (PDF)
145Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance
Aids, 2018, 32, 327-335
2.516Citations (PDF)
146Virologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysis
F1000Research, 2018, 7, 1359
0.532Citations (PDF)
147HIV drug resistance in sub-Saharan Africa: public health questions and the potential role of real-world data and mathematical modelling0.429Citations (PDF)
148IeDEA–WHO Research-Policy Collaboration: contributing real-world evidence to HIV progress reporting and guideline development0.419Citations (PDF)
149The contribution of observational studies in supporting the WHO ‘treat all’ recommendation for HIV/AIDS0.414Citations (PDF)
150Large variations in iron input to an oligotrophic Baltic Sea estuary: impact on sedimentary phosphorus burial
Biogeosciences, 2018, 15, 6979-6996
3.158Citations (PDF)
151Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation3.49Citations (PDF)
152High prevalence of binge drinking among people living with HIV in four African countries3.444Citations (PDF)
153Developing WHO guidelines: Time to formally include evidence from mathematical modelling studies
F1000Research, 2018, 6, 1584
0.535Citations (PDF)
154Vivianite formation in methane-rich deep-sea sediments from the South China Sea
Biogeosciences, 2018, 15, 6329-6348
3.141Citations (PDF)
155Estimating the contribution of studies in network meta-analysis: paths, flows and streams
F1000Research, 2018, 7, 610
0.50Citations (PDF)
156No Impact of Hepatitis B Virus Infection on Early Mortality Among Human Immunodeficiency Virus–Infected Patients in Southern Africa
Clinical Infectious Diseases, 2018, 67, 1310-1311
5.24Citations (PDF)
157Global diffusive fluxes of methane in marine sediments
Nature Geoscience, 2018, 11, 421-425
11.3294Citations (PDF)
158Post-depositional formation of vivianite-type minerals alters sediment phosphorus records
Biogeosciences, 2018, 15, 861-883
3.155Citations (PDF)
159Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis
Medical Decision Making, 2018, 38, 719-729
2.28Citations (PDF)
160Planning a future randomized clinical trial based on a network of relevant past trials
Trials, 2018, 19,
2.033Citations (PDF)
161Methods to systematically review and meta-analyse observational studies: a systematic scoping review of recommendations2.5341Citations (PDF)
162Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysis4.945Citations (PDF)
163Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis
Clinical Infectious Diseases, 2018, 67, 1643-1652
5.291Citations (PDF)
164Estimating the contribution of studies in network meta-analysis: paths, flows and streams
F1000Research, 2018, 7, 610
0.540Citations (PDF)
165Estimating the contribution of studies in network meta-analysis: paths, flows and streams
F1000Research, 2018, 7, 610
0.522Citations (PDF)
166Discipline-specific open access publishing practices and barriers to change: an evidence-based review
F1000Research, 2018, 7, 1925
0.541Citations (PDF)
167Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord4.925Citations (PDF)
168Outcomes of HIV‐positive patients lost to follow‐up in African treatment programmes1.9101Citations (PDF)
169Effect of laminar airflow ventilation on surgical site infections: a systematic review and meta-analysis16.5181Citations (PDF)
170Effect of standardized training on the reliability of the Cochrane risk of bias assessment tool: a prospective study4.754Citations (PDF)
171Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study
Lancet HIV,the, 2017, 4, e251-e259
7.912Citations (PDF)
172Iron oxide reduction in methane-rich deep Baltic Sea sediments4.8127Citations (PDF)
173Series: Pragmatic trials and real world evidence: Paper 6. Outcome measures in the real world3.748Citations (PDF)
174Systematic Review and Meta-Analysis of Randomized Controlled Trials Evaluating Prophylactic Intra-Operative Wound Irrigation for the Prevention of Surgical Site Infections
Surgical Infections, 2017, 18, 508-519
1.290Citations (PDF)
175Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer
JAMA Oncology, 2017, 3, 1237
14.3455Citations (PDF)
176Meta-analysis of lower perioperative blood glucose target levels for reduction of surgical-site infection
British Journal of Surgery, 2017, 104, e95-e105
0.3144Citations (PDF)
177New‐onset type 2 diabetes mellitus among patients receiving HIV care at Newlands Clinic, Harare, Zimbabwe: retrospective cohort analysis1.919Citations (PDF)
178Series: Pragmatic trials and real world evidence: Paper 2. Setting, sites, and investigator selection3.740Citations (PDF)
179Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM
Aids, 2017, 31, 1859-1866
2.517Citations (PDF)
180Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study
Clinical Infectious Diseases, 2017, 65, 1316-1326
5.255Citations (PDF)
181Anaerobic Methane-Oxidizing Microbial Community in a Coastal Marine Sediment: Anaerobic Methanotrophy Dominated by ANME-3
Microbial Ecology, 2017, 74, 608-622
3.344Citations (PDF)
182Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations3.9446Citations (PDF)
183Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
Lancet, The, 2017, 389, 505-518
62.11,052Citations (PDF)
184Twelve‐year mortality in adults initiating antiretroviral therapy in South Africa3.460Citations (PDF)
185HIV transmission and retention in care among HIV‐exposed children enrolled in Malawi's prevention of mother‐to‐child transmission programme3.435Citations (PDF)
186Perspective: An Extension of the STROBE Statement for Observational Studies in Nutritional Epidemiology (STROBE-nut): Explanation and Elaboration
Advances in Nutrition, 2017, 8, 652-678
7.761Citations (PDF)
187Series: Pragmatic trials and real world evidence: Paper 8. Data collection and management3.736Citations (PDF)
188All-cause mortality in HIV-positive adults starting combination antiretroviral therapy
Aids, 2017, 31, S31-S40
2.528Citations (PDF)
189The cascade of care to prevent mother‐to‐child transmission in Rio de Janeiro, Brazil, 1996–2013: improving but still some way to go1.93Citations (PDF)
190Body mass index in midlife and dementia: Systematic review and meta‐regression analysis of 589,649 men and women followed in longitudinal studies2.4228Citations (PDF)
191Human papillomavirus antibody response following HAART initiation among MSM
Aids, 2017, 31, 561-569
2.515Citations (PDF)
192Regional Variation of Cost of Care in the Last 12 Months of Life in Switzerland
Medical Care, 2017, 55, 155-163
1.837Citations (PDF)
193Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study
Lancet Oncology, The, 2017, 18, 1348-1359
27.459Citations (PDF)
194Awareness and management of elevated blood pressure among human immunodeficiency virus–infected adults receiving antiretroviral therapy in urban Zambia: a call to action2.112Citations (PDF)
195Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): A case-series, systematic review and meta-analysis
Oral Oncology, 2017, 75, 28-34
2.457Citations (PDF)
196Series: Pragmatic trials and real world evidence: Paper 5. Usual care and real life comparators3.751Citations (PDF)
197Bibliographic study showed improving statistical methodology of network meta-analyses published between 1999 and 20153.7121Citations (PDF)
198HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies3.449Citations (PDF)
199Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison0.77Citations (PDF)
200Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa
BMC Cancer, 2017, 17,
2.916Citations (PDF)
201Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa2.636Citations (PDF)
202The origin of methane in the East Siberian Arctic Shelf unraveled with triple isotope analysis
Biogeosciences, 2017, 14, 2283-2292
3.162Citations (PDF)
203Reply to El-Mallawany et al
Clinical Infectious Diseases, 2017, 64, 819-820
5.20Citations (PDF)
204Life expectancy in HIV-positive persons in Switzerland
Aids, 2017, 31, 427-436
2.5240Citations (PDF)
205CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach2.37Citations (PDF)
206Suicide in adolescents: findings from the Swiss National cohort3.126Citations (PDF)
207Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia
Clinical Infectious Diseases, 2017, 64, 1343-1349
5.256Citations (PDF)
208Developing WHO guidelines: Time to formally include evidence from mathematical modelling studies
F1000Research, 2017, 6, 1584
0.561Citations (PDF)
209Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study
PLoS Medicine, 2017, 14, e1002468
8.0130Citations (PDF)
210Space-Time Clustering of Childhood Leukemia: Evidence of an Association with ETV6-RUNX1 (TEL-AML1) Fusion
PLoS ONE, 2017, 12, e0170020
2.313Citations (PDF)
211Open data: support from Swiss funder
Nature, 2017, 547, 403-403
37.90Citations (PDF)
212Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program
Clinical Infectious Diseases, 2016, 63, 1227-1235
5.2153Citations (PDF)
213Methods and Processes of Developing the Strengthening the Reporting of Observational Studies in Epidemiology—Veterinary (STROBE-Vet) Statement
Journal of Food Protection, 2016, 79, 2211-2219
2.516Citations (PDF)
214Hepatitis C in HIV‐infected individuals: a systematic review and meta‐analysis of estimated prevalence in Africa3.426Citations (PDF)
215Anaerobic oxidation of methane alters sediment records of sulfur, iron and phosphorus in the Black Sea
Biogeosciences, 2016, 13, 5333-5355
3.194Citations (PDF)
216Socioeconomic disparities in childhood cancer survival in Switzerland
International Journal of Cancer, 2016, 138, 2856-2866
4.348Citations (PDF)
217Iron‐dependent anaerobic oxidation of methane in coastal surface sediments: Potential controls and impact3.781Citations (PDF)
218Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case‐control study in the Swiss HIV cohort study
International Journal of Cancer, 2016, 138, 1732-1740
4.386Citations (PDF)
219Dying among older adults in Switzerland: who dies in hospital, who dies in a nursing home?2.414Citations (PDF)
220Methods and Processes of Developing the Strengthening the Reporting of Observational Studies in Epidemiology – Veterinary (STROBE-Vet) Statement1.952Citations (PDF)
221Methods and Processes of Developing the Strengthening the Reporting of Observational Studies in Epidemiology – Veterinary (STROBE‐Vet) Statement
Zoonoses and Public Health, 2016, 63, 651-661
2.218Citations (PDF)
222Explanation and Elaboration Document for the STROBE‐Vet Statement: Strengthening the Reporting of Observational Studies in Epidemiology – Veterinary Extension
Zoonoses and Public Health, 2016, 63, 662-698
2.249Citations (PDF)
223Reporting guidelines for health care simulation research: Extensions to the CONSORT and STROBE statements1.023Citations (PDF)
224Pulmonary artery pressure and arterial oxygen saturation in people living at high or low altitude: systematic review and meta-analysis
Journal of Applied Physiology, 2016, 121, 1151-1159
2.876Citations (PDF)
225Methods and processes of developing the strengthening the reporting of observational studies in epidemiology − veterinary (STROBE-Vet) statement
Preventive Veterinary Medicine, 2016, 134, 188-196
2.188Citations (PDF)
226Explanation and Elaboration Document for the STROBE-Vet Statement: Strengthening the Reporting of Observational Studies in Epidemiology—Veterinary Extension1.964Citations (PDF)
227When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries1.826Citations (PDF)
228Standard Genotyping Overestimates Transmission of Mycobacterium tuberculosis among Immigrants in a Low-Incidence Country4.0109Citations (PDF)
229Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia
Clinical Infectious Diseases, 2016, 63, 1245-1253
5.224Citations (PDF)
230Strengthening the Reporting of Observational Studies in Epidemiology – nutritional epidemiology (STROBE‐nut): An extension of the STROBE statement
Nutrition Bulletin, 2016, 41, 240-251
2.8287Citations (PDF)
231Association between hepatitis B co‐infection and elevated liver stiffness among <scp>HIV</scp>‐infected adults in Lusaka, Zambia1.919Citations (PDF)
232HIV and human herpesvirus 8 co-infection across the globe: Systematic review and meta-analysis4.390Citations (PDF)
233Record linkage to correct under‐ascertainment of cancers in HIV cohorts: The Sinikithemba HIV clinic linkage project
International Journal of Cancer, 2016, 139, 1209-1216
4.329Citations (PDF)
234GetReal in mathematical modelling: a review of studies predicting drug effectiveness in the real world
Research Synthesis Methods, 2016, 7, 264-277
4.826Citations (PDF)
235Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response
Journal of Infectious Diseases, 2016, 214, 1498-1506
3.729Citations (PDF)
236Reporting guidelines for health care simulation research: extensions to the CONSORT and STROBE statements3.8353Citations (PDF)
237Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared2.124Citations (PDF)
238Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
Lancet Oncology, The, 2016, 17, 1697-1708
27.4701Citations (PDF)
239Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages
Nature Genetics, 2016, 48, 1535-1543
25.2429Citations (PDF)
240New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective
Lancet Infectious Diseases, The, 2016, 16, e276-e287
16.5774Citations (PDF)
241New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective
Lancet Infectious Diseases, The, 2016, 16, e288-e303
16.5784Citations (PDF)
242A systematic review and meta-analysis including GRADE qualification of the risk of surgical site infections after prophylactic negative pressure wound therapy compared with conventional dressings in clean and contaminated surgery
Medicine (United States), 2016, 95, e4673
1.285Citations (PDF)
243Reporting Guidelines for Health Care Simulation Research
Simulation in Healthcare, 2016, 11, 238-248
1.7367Citations (PDF)
244Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe3.3384Citations (PDF)
245Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta‐analysis4.335Citations (PDF)
246Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi
Aids, 2016, 30, 953-962
2.515Citations (PDF)
247Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi’s sarcoma in five countries across sub-Saharan Africa
BMC Cancer, 2016, 16,
2.929Citations (PDF)
248Contribution of Genetic Background and Clinical Risk Factors to Low-Trauma Fractures in Human Immunodeficiency Virus (HIV)-Positive Persons: The Swiss HIV Cohort Study0.87Citations (PDF)
249Absence of Active Hepatitis C Virus Infection in Human Immunodeficiency Virus Clinics in Zambia and Mozambique0.810Citations (PDF)
250Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study0.818Citations (PDF)
251Tuberculosis in Cape Town: An age-structured transmission model
Epidemics, 2016, 14, 54-61
2.233Citations (PDF)
252Noninferiority is (too) common in noninferiority trials3.79Citations (PDF)
253Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen3.14Citations (PDF)
254Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy4.961Citations (PDF)
255CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study2.937Citations (PDF)
256HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort Study
Clinical Infectious Diseases, 2016, 62, 115-122
5.269Citations (PDF)
257Strengthening the Reporting of Observational Studies in Epidemiology—Nutritional Epidemiology (STROBE-nut): An Extension of the STROBE Statement
PLoS Medicine, 2016, 13, e1002036
8.0437Citations (PDF)
258Tuberculosis Mortality and Living Conditions in Bern, Switzerland, 1856-1950
PLoS ONE, 2016, 11, e0149195
2.318Citations (PDF)
259Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia
PLoS ONE, 2016, 11, e0152043
2.336Citations (PDF)
260Rapid Sediment Accumulation Results in High Methane Effluxes from Coastal Sediments
PLoS ONE, 2016, 11, e0161609
2.396Citations (PDF)
261Influenza Pandemics and Tuberculosis Mortality in 1889 and 1918: Analysis of Historical Data from Switzerland
PLoS ONE, 2016, 11, e0162575
2.343Citations (PDF)
262Virological Outcome and Management of Persistent Low-Level Viraemia in HIV-1-Infected Patients: 11 Years of the Swiss HIV Cohort Study
Antiviral Therapy, 2015, 20, 165-175
1.953Citations (PDF)
263Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children aged 1-5 Years
Epidemiology, 2015, , 1
2.821Citations (PDF)
264Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource Settings1.819Citations (PDF)
265Brief Report1.827Citations (PDF)
266Implementation and Operational Research1.810Citations (PDF)
267Authors' Reply1.80Citations (PDF)
268Accounting for and responding to HIV-associated mortality
Aids, 2015, , 1
2.56Citations (PDF)
269The Cost-Effectiveness of Monitoring Strategies for Antiretroviral Therapy of HIV Infected Patients in Resource-Limited Settings: Software Tool
PLoS ONE, 2015, 10, e0119299
2.39Citations (PDF)
270Effect of Health Risk Assessment and Counselling on Health Behaviour and Survival in Older People: A Pragmatic Randomised Trial
PLoS Medicine, 2015, 12, e1001889
8.061Citations (PDF)
271PEDro or Cochrane to Assess the Quality of Clinical Trials? A Meta-Epidemiological Study
PLoS ONE, 2015, 10, e0132634
2.3159Citations (PDF)
272Effectiveness of Personal Protective Equipment for Healthcare Workers Caring for Patients with Filovirus Disease: A Rapid Review
PLoS ONE, 2015, 10, e0140290
2.353Citations (PDF)
273Authors' Reply1.80Citations (PDF)
274Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 20130.820Citations (PDF)
275Increases in Condomless Sex in the Swiss HIV Cohort Study
Open Forum Infectious Diseases, 2015, 2, ofv077-ofv077
0.837Citations (PDF)
276Vivianite is a major sink for phosphorus in methanogenic coastal surface sediments4.8188Citations (PDF)
277Estimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data
Epidemiology, 2015, 26, 653-660
2.890Citations (PDF)
278The authors’ reply: Population mixing and childhood leukaemia5.30Citations (PDF)
279Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
Lancet, The, 2015, 386, 857-866
62.1758Citations (PDF)
280Background Ionizing Radiation and the Risk of Childhood Cancer: A Census-Based Nationwide Cohort Study8.3129Citations (PDF)
281Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis
Lancet HIV,the, 2015, 2, e271-e278
7.9114Citations (PDF)
282Adiposity and cancer risk: new mechanistic insights from epidemiology
Nature Reviews Cancer, 2015, 15, 484-498
60.7598Citations (PDF)
283Comparison of noninferiority margins reported in protocols and publications showed incomplete and inconsistent reporting3.717Citations (PDF)
284CD4+ T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa4.911Citations (PDF)
285A Swiss paradox? Higher income inequality of municipalities is associated with lower mortality in Switzerland5.326Citations (PDF)
286HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study
BMC Cancer, 2015, 15,
2.910Citations (PDF)
287Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland
Aids, 2015, 29, 231-238
2.535Citations (PDF)
288Immunodeficiency in Children Starting Antiretroviral Therapy in Low-, Middle-, and High-Income Countries1.853Citations (PDF)
289Population mixing and the risk of childhood leukaemia in Switzerland: a census-based cohort study5.310Citations (PDF)
290Childhood cancer and residential exposure to highways: a nationwide cohort study5.353Citations (PDF)
291Measuring Intensity of End of Life Care: A Systematic Review
PLoS ONE, 2015, 10, e0123764
2.389Citations (PDF)
292Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study
Lancet HIV,the, 2015, 2, e368-e375
7.933Citations (PDF)
293Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: “STROBE-RDS” statement3.7224Citations (PDF)
294HHV‐8 seroprevalence in HIV‐positive and HIV‐negative populations
International Journal of Cancer, 2015, 136, 1243-1243
4.34Citations (PDF)
295Occupational exposure to magnetic fields and electric shocks and risk of ALS: The Swiss National Cohort2.533Citations (PDF)
296Tracking a Tuberculosis Outbreak Over 21 Years: Strain-Specific Single-Nucleotide Polymorphism Typing Combined With Targeted Whole-Genome Sequencing
Journal of Infectious Diseases, 2015, 211, 1306-1316
3.788Citations (PDF)
297Iron-Mediated Anaerobic Oxidation of Methane in Brackish Coastal Sediments11.1296Citations (PDF)
298Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices1.517Citations (PDF)
299Poor Reliability between Cochrane Reviewers and Blinded External Reviewers When Applying the Cochrane Risk of Bias Tool in Physical Therapy Trials
PLoS ONE, 2014, 9, e96920
2.3109Citations (PDF)
300Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia‐Pacific, sub‐Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration3.449Citations (PDF)
301Immunodeficiency at the Start of Combination Antiretroviral Therapy in Low-, Middle-, and High-Income Countries1.8150Citations (PDF)
302Timing of bacterial carriage sampling in vaccine trials: A modelling study
Epidemics, 2014, 9, 8-17
2.212Citations (PDF)
303Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study0.876Citations (PDF)
304Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data
British Journal of Cancer, 2014, 111, 33-45
5.561Citations (PDF)
305Integrated care programmes for adults with chronic conditions: a meta-review1.0218Citations (PDF)
306Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies
PLoS Medicine, 2014, 11, e1001718
8.0115Citations (PDF)
307The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies5.48,973Citations (PDF)
308Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration5.42,636Citations (PDF)
309Tracing of Patients Lost to Follow-up and HIV Transmission1.832Citations (PDF)
310Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries1.312Citations (PDF)
311Differences in the intrinsic immunogenicity and allergenicity of B et v 1 and related food allergens revealed by site‐directed mutagenesis6.732Citations (PDF)
312Cotrimoxazole prophylactic treatment prevents malaria in children in sub‐Saharan Africa: systematic review and meta‐analysis1.933Citations (PDF)
313Incidence Rate of Kaposi Sarcoma in HIV-Infected Patients on Antiretroviral Therapy in Southern Africa1.856Citations (PDF)
314Impact of viral load and the duration of primary infection on HIV transmission
Aids, 2014, 28, 1021-1029
2.552Citations (PDF)
315Observational Research on NCDs in HIV-Positive Populations1.834Citations (PDF)
316Viral load versus CD4+ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa
Aids, 2014, 28, 2451-2460
2.513Citations (PDF)
317Individual and spousal education, mortality and life expectancy in Switzerland: a national cohort study2.932Citations (PDF)
318Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study
Clinical Infectious Diseases, 2014, 58, 285-294
5.279Citations (PDF)
319Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV4.937Citations (PDF)
320Suicide assisted by right-to-die associations: a population based cohort study4.9105Citations (PDF)
321What does your neighbourhood say about you? A study of life expectancy in 1.3 million Swiss neighbourhoods2.938Citations (PDF)
322Delayed HIV diagnosis and initiation of antiretroviral therapy
Aids, 2014, 28, 2297-2306
2.542Citations (PDF)
323Response to Rezaeian: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) extension for ecological studies3.75Citations (PDF)
324Kaposi's Sarcoma in HIV‐infected patients in South Africa: Multicohort study in the antiretroviral therapy era
International Journal of Cancer, 2014, 135, 2644-2652
4.354Citations (PDF)
325Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals3.133Citations (PDF)
326Social Meets Molecular: Combining Phylogenetic and Latent Class Analyses to Understand HIV-1 Transmission in Switzerland
American Journal of Epidemiology, 2014, 179, 1514-1525
3.330Citations (PDF)
327Long-term Mortality in HIV-Positive Individuals Virally Suppressed for &gt;3 Years With Incomplete CD4 Recovery
Clinical Infectious Diseases, 2014, 58, 1312-1321
5.2170Citations (PDF)
328Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement16.5237Citations (PDF)
329Fish or n3‐PUFA intake and body composition: a systematic review and meta‐analysis
Obesity Reviews, 2014, 15, 657-665
7.5133Citations (PDF)
330Decreasing Risk of Hepatitis A Infection in León, Nicaragua: Evidence from Cross-Sectional and Longitudinal Seroepidemiology Studies
PLoS ONE, 2014, 9, e87643
2.312Citations (PDF)
331Homicide-suicides compared to homicides and suicides: Systematic review and meta-analysis2.075Citations (PDF)
332Impact of definitions of loss to follow-up (LTFU) in antiretroviral therapy program evaluation: variation in the definition can have an appreciable impact on estimated proportions of LTFU3.761Citations (PDF)
333Euthanasia and Assisted Suicide in Selected European Countries and US States
Medical Care, 2013, 51, 938-944
1.8170Citations (PDF)
334High life in the sky? Mortality by floor of residence in Switzerland5.337Citations (PDF)
335Mammografie-Screening0.12Citations (PDF)
336Cohort study of trials submitted to ethics committee identified discrepant reporting of outcomes in publications3.728Citations (PDF)
337Religion and Suicide in Patients with Mental Illness or Cancer2.217Citations (PDF)
338PEDro's bias: summary quality scores should not be used in meta-analysis3.779Citations (PDF)
339Tuberculosis and the risk of opportunistic infections and cancers in HIV‐infected patients starting ART in Southern Africa1.921Citations (PDF)
340Impact of unlinked deaths and coding changes on mortality trends in the Swiss National Cohort3.1232Citations (PDF)
341Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings
Aids, 2013, 27, 1483-1492
2.548Citations (PDF)
342Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples
The Cochrane Library, 2013, 2013,
2.1114Citations (PDF)
343Immune Recovery After Starting ART in HIV-Infected Patients Presenting and Not Presenting With Tuberculosis in South Africa1.825Citations (PDF)
344Kaposi Sarcoma-Associated Herpes Virus and Response to Antiretroviral Therapy1.812Citations (PDF)
345CD4 Count Slope and Mortality in HIV-Infected Patients on Antiretroviral Therapy1.823Citations (PDF)
346Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study
Journal of Infectious Diseases, 2013, 208, 1454-1458
3.777Citations (PDF)
347Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
PLoS Medicine, 2013, 10, e1001418
8.0353Citations (PDF)
348When to Start Antiretroviral Therapy in Children Aged 2–5 Years: A Collaborative Causal Modelling Analysis of Cohort Studies from Southern Africa
PLoS Medicine, 2013, 10, e1001555
8.033Citations (PDF)
349HIV Infection Disrupts the Sympatric Host–Pathogen Relationship in Human Tuberculosis
PLoS Genetics, 2013, 9, e1003318
3.290Citations (PDF)
350Predictors of CD4+ T-Cell Counts of HIV Type 1–Infected Persons After Virologic Failure of All 3 Original Antiretroviral Drug Classes
Journal of Infectious Diseases, 2013, 207, 759-767
3.77Citations (PDF)
351The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/µL in the Post–Combination Antiretroviral Therapy Era
Clinical Infectious Diseases, 2013, 57, 1038-1047
5.2100Citations (PDF)
352Re: "Need For More Individual-Level Meta-Analyses In Social Epidemiology: Example of Job Strain and Coronary Heart Disease"3.34Citations (PDF)
353Origin of Minority Drug-Resistant HIV-1 Variants in Primary HIV-1 Infection
Journal of Infectious Diseases, 2013, 208, 1102-1112
3.739Citations (PDF)
354Zidovudine impairs immunological recovery on first-line antiretroviral therapy
Aids, 2013, 27, 2225-2232
2.515Citations (PDF)
355Outcomes of antiretroviral treatment programmes in rural Lesotho: health centres and hospitals compared3.418Citations (PDF)
356Incidence and Risk Factors of Homicide–Suicide in Swiss Households: National Cohort Study
PLoS ONE, 2013, 8, e53714
2.323Citations (PDF)
357Comparison of Treatment Outcomes of New Smear-Positive Pulmonary Tuberculosis Patients by HIV and Antiretroviral Status in a TB/HIV Clinic, Malawi
PLoS ONE, 2013, 8, e56248
2.364Citations (PDF)
358Treatment Response and Mortality among Patients Starting Antiretroviral Therapy with and without Kaposi Sarcoma: A Cohort Study
PLoS ONE, 2013, 8, e64392
2.343Citations (PDF)
359Are They Really Lost? “True” Status and Reasons for Treatment Discontinuation among HIV Infected Patients on Antiretroviral Therapy Considered Lost to Follow Up in Urban Malawi
PLoS ONE, 2013, 8, e75761
2.383Citations (PDF)
360Temporal Trends in the Characteristics of Children at Antiretroviral Therapy Initiation in Southern Africa: The IeDEA-SA Collaboration
PLoS ONE, 2013, 8, e81037
2.337Citations (PDF)
361Retention in Care of HIV-Infected Children from HIV Test to Start of Antiretroviral Therapy: Systematic Review
PLoS ONE, 2013, 8, e56446
2.341Citations (PDF)
362Tumorscreening0.11Citations (PDF)
363Tumorscreening – Grundlagen, Evaluation und Implementation0.15Citations (PDF)
364Monitoring of Antiretroviral Therapy and Mortality in HIV Programmes in Malawi, South Africa and Zambia: Mathematical Modelling Study
PLoS ONE, 2013, 8, e57611
2.327Citations (PDF)
365Tuberculosis in Antiretroviral Treatment Programs in Lower Income Countries: Availability and Use of Diagnostics and Screening
PLoS ONE, 2013, 8, e77697
2.323Citations (PDF)
366Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy2.453Citations (PDF)
367Cohort Profile: The international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa4.9248Citations (PDF)
368Cohort Profile: The Swiss Childhood Cancer Survivor Study4.9156Citations (PDF)
369Variability of Growth in Children Starting Antiretroviral Treatment in Southern Africa
Pediatrics, 2012, 130, e966-e977
4.551Citations (PDF)
370All-cause mortality in treated HIV-infected adults with CD4 &gt;=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration 4.9238Citations (PDF)
371Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection
British Journal of Cancer, 2012, 106, 447-452
5.577Citations (PDF)
372STrengthening the Reporting of OBservational studies in Epidemiology: Molecular Epidemiology STROBE-ME. An extension of the STROBE statement2.917Citations (PDF)
373Authors' response to: Childhood cancer and nuclear power plants in Switzerland: a census-based cohort study: Figure 14.91Citations (PDF)
374Mycobacterium tuberculosis Transmission in a Country with Low Tuberculosis Incidence: Role of Immigration and HIV Infection4.043Citations (PDF)
375STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement
Mutagenesis, 2012, 27, 17-29
5.232Citations (PDF)
376Missed opportunities to prevent mother-to-child-transmission
Aids, 2012, 26, 2361-2373
2.5158Citations (PDF)
377Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South Africa1.8125Citations (PDF)
378Mortality and loss to follow-up in the first year of ART
Aids, 2012, 26, 365-373
2.567Citations (PDF)
379Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa
Aids, 2012, 26, 1403-1413
2.532Citations (PDF)
380The causal effect of switching to second-line ART in programmes without access to routine viral load monitoring
Aids, 2012, 26, 57-65
2.542Citations (PDF)
381Outcomes of Antiretroviral Treatment Programs in Rural Southern Africa1.872Citations (PDF)
382Tenofovir in Second-Line ART in Zambia and South Africa1.814Citations (PDF)
383The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure1.99Citations (PDF)
384Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub‐Saharan Africa: systematic review and meta‐analysis1.9218Citations (PDF)
385CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials5.42,054Citations (PDF)
386Effect of Preventive Interventions in Mentally Ill Parents on the Mental Health of the Offspring: Systematic Review and Meta-Analysis2.3383Citations (PDF)
387A Swiss neighbourhood index of socioeconomic position: development and association with mortality2.9187Citations (PDF)
388Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings2.68Citations (PDF)
389Tuberculosis in HIV-Negative and HIV-Infected Patients in a Low-Incidence Country: Clinical Characteristics and Treatment Outcomes
PLoS ONE, 2012, 7, e34186
2.316Citations (PDF)
390Effect of Mutation and Genetic Background on Drug Resistance in Mycobacterium tuberculosis4.1127Citations (PDF)
391STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE‐ME): An extension of the STROBE statement3.073Citations (PDF)
392Characteristics of adults and children diagnosed with tuberculosis in Lilongwe, Malawi: findings from an integrated HIV/TB clinic1.99Citations (PDF)
393Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort Study
PLoS Medicine, 2012, 9, e1001304
8.0222Citations (PDF)
394Childhood cancer and nuclear power plants in Switzerland: a census-based cohort study4.959Citations (PDF)
395Protein unfolding strongly modulates the allergenicity and immunogenicity of Pru p 3, the major peach allergen6.178Citations (PDF)
396Sensitization Prevalence, Antibody Cross-Reactivity and Immunogenic Peptide Profile of Api g 2, the Non-Specific Lipid Transfer Protein 1 of Celery
PLoS ONE, 2011, 6, e24150
2.361Citations (PDF)
397Domains of physical activity and all-cause mortality: systematic review and dose–response meta-analysis of cohort studies4.9744Citations (PDF)
398Reporting of noninferiority trials was incomplete in trial registries3.715Citations (PDF)
399STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology STROBE-ME: an extension of the STROBE statement3.747Citations (PDF)
400Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: Systematic review and meta-analysis
Vaccine, 2011, 29, 9711-9721
3.169Citations (PDF)
401Assessing Protein Immunogenicity with a Dendritic Cell Line-Derived Endolysosomal Degradome
PLoS ONE, 2011, 6, e17278
2.369Citations (PDF)
402“Pseudo-Beijing”: Evidence for Convergent Evolution in the Direct Repeat Region of Mycobacterium tuberculosis
PLoS ONE, 2011, 6, e24737
2.354Citations (PDF)
403Association between Variants of the Leptin Receptor Gene (LEPR) and Overweight: A Systematic Review and an Analysis of the CoLaus Study
PLoS ONE, 2011, 6, e26157
2.368Citations (PDF)
404Aircraft Noise and Myocardial Infarction Mortality
Epidemiology, 2011, 22, 284
2.80Citations (PDF)
405Virologic Failure and Second-Line Antiretroviral Therapy in Children in South Africa—The IeDEA Southern Africa Collaboration1.8118Citations (PDF)
406Tuberculosis in HIV programmes in lower-income countries: practices and risk factors1.335Citations (PDF)
407In reply to ‘Pre-screening with GeneXpert® MTB/RIF may increase use of isoniazid preventive therapy in antiretroviral programmes’ [Correspondence]1.31Citations (PDF)
408Time to Initiation of Antiretroviral Therapy Among Patients With HIV-Associated Tuberculosis in Cape Town, South Africa1.836Citations (PDF)
409HIV-1–related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes
Blood, 2011, 117, 6100-6108
4.8110Citations (PDF)
410Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius
Blood, 2011, 117, 6375-6382
4.8304Citations (PDF)
411Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy – The IeDEA Southern Africa Collaboration1.922Citations (PDF)
412Role of Hepatitis C virus genotype 3 in liver fibrosis progression - a systematic review and meta-analysis
Journal of Viral Hepatitis, 2011, 18, 745-759
1.9144Citations (PDF)
413STrengthening the Reporting of OBservational studies in Epidemiology — Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement
Preventive Medicine, 2011, 53, 377-387
2.88Citations (PDF)
414STrengthening the reporting of OBservational studies in Epidemiology—Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement5.323Citations (PDF)
415Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa2.522Citations (PDF)
416Proteomic profiling of birch (Betula verrucosa) pollen extracts from different origins
Proteomics, 2011, 11, 1486-1498
3.153Citations (PDF)
417Molecular characterization of Api g 2, a novel allergenic member of the lipid‐transfer protein 1 family from celery stalks4.032Citations (PDF)
418Mortality from road traffic accidents in Switzerland: Longitudinal and spatial analyses5.566Citations (PDF)
419Uses and misuses of the STROBE statement: bibliographic study
BMJ Open, 2011, 1, e000048
1.9254Citations (PDF)
420Meta-Analysis and Dose-Response Metaregression: Circulating Insulin-Like Growth Factor I (IGF-I) and Mortality4.0138Citations (PDF)
421A Randomized Trial of Effects of Health Risk Appraisal Combined With Group Sessions or Home Visits on Preventive Behaviors in Older Adults3.469Citations (PDF)
422Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa
Aids, 2011, 25, 1761-1769
2.5105Citations (PDF)
423Ageing with HIV: medication use and risk for potential drug-drug interactions3.1145Citations (PDF)
424Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
BMJ: British Medical Journal, 2011, 342, c7086-c7086
0.11,017Citations (PDF)
425Correcting Mortality for Loss to Follow-Up: A Nomogram Applied to Antiretroviral Treatment Programmes in Sub-Saharan Africa
PLoS Medicine, 2011, 8, e1000390
8.0139Citations (PDF)
426Intravaginal Practices, Bacterial Vaginosis, and HIV Infection in Women: Individual Participant Data Meta-analysis
PLoS Medicine, 2011, 8, e1000416
8.0243Citations (PDF)
427STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): An Extension of the STROBE Statement
PLoS Medicine, 2011, 8, e1001117
8.0157Citations (PDF)
428Outcomes of Antiretroviral Therapy in the Swiss HIV Cohort Study: Latent Class Analysis
AIDS and Behavior, 2011, 16, 245-255
1.923Citations (PDF)
429Is Aboriginal Food Less Allergenic? Comparing IgE-Reactivity of Eggs from Modern and Ancient Chicken Breeds in a Cohort of Allergic Children
PLoS ONE, 2011, 6, e19062
2.314Citations (PDF)
430Estimating Loss to Follow-Up in HIV-Infected Patients on Antiretroviral Therapy: The Effect of the Competing Risk of Death in Zambia and Switzerland
PLoS ONE, 2011, 6, e27919
2.361Citations (PDF)
431A model for radiofrequency electromagnetic field predictions at outdoor and indoor locations in the context of epidemiological research
Bioelectromagnetics, 2010, 31, 226-236
1.372Citations (PDF)
432Aircraft Noise, Air Pollution, and Mortality From Myocardial Infarction
Epidemiology, 2010, 21, 829-836
2.8179Citations (PDF)
433Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007
Aids, 2010, 24, 2263-2270
2.5200Citations (PDF)
434Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study
Aids, 2010, 24, 2717-2725
2.580Citations (PDF)
435CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
BMJ: British Medical Journal, 2010, 340, c869-c869
0.16,574Citations (PDF)
436The Role of Lipid Transfer Proteins in Allergic Diseases4.0151Citations (PDF)
437Mapping the Interactions between a Major Pollen Allergen and Human IgE Antibodies
Structure, 2010, 18, 1011-1021
3.852Citations (PDF)
438Incident cancer burden attributable to excess body mass index in 30 European countries4.3253Citations (PDF)
439Characterization of plant food allergens: An overview on physicochemical and immunological techniques4.035Citations (PDF)
440Source of funding in experimental studies of mobile phone use on health: Update of systematic review
Comptes Rendus Physique, 2010, 11, 622-627
1.08Citations (PDF)
441Panallergens and their impact on the allergic patient2.1283Citations (PDF)
442Clinical trial: prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations – the Bristol Helicobacter Project3.764Citations (PDF)
443Mortality after failure of antiretroviral therapy in sub‐Saharan Africa1.973Citations (PDF)
444Authors' response: the importance of asking the right question1.90Citations (PDF)
445Growth response to antiretroviral treatment in HIV-infected children: a cohort study from Lilongwe, Malawi1.956Citations (PDF)
446Impact of Single Nucleotide Polymorphisms and of Clinical Risk Factors on New‐Onset Diabetes Mellitus in HIV‐Infected Individuals
Clinical Infectious Diseases, 2010, 51, 1090-1098
5.229Citations (PDF)
447Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials4.926Citations (PDF)
448Religion and assisted and non-assisted suicide in Switzerland: National Cohort Study4.967Citations (PDF)
449Book Review A Decade of HAART: The Development and Global Impact of Highly Active Antiretroviral Therapy Edited by José M.  Zuninga , Alan  Whiteside , Amin  Ghaziani , and John G.  Bartlett New York: Oxford University Press, 2008. 464 pp $130 (hardcover).
Clinical Infectious Diseases, 2010, 50, 942-943
5.20Citations (PDF)
450Long‐Term Antibiotic Treatment for Crohn's Disease: Systematic Review and Meta‐Analysis of Placebo‐Controlled Trials
Clinical Infectious Diseases, 2010, 50, 473-480
5.2101Citations (PDF)
451Early Mortality and Loss to Follow-up in HIV-Infected Children Starting Antiretroviral Therapy in Southern Africa1.892Citations (PDF)
452Mortality Associated With Discordant Responses to Antiretroviral Therapy in Resource-Constrained Settings1.839Citations (PDF)
453Suicide in HIV-Infected Individuals and the General Population in Switzerland, 1988–2008
American Journal of Psychiatry, 2010, 167, 143-150
8.8119Citations (PDF)
454Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study
BMJ: British Medical Journal, 2010, 341, c3515-c3515
0.1522Citations (PDF)
455Naturally processed T cell–activating peptides of the major birch pollen allergen6.170Citations (PDF)
456Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis1.1273Citations (PDF)
457Targeting the cysteine-stabilized fold of Art v 1 for immunotherapy of Artemisia pollen allergy
Molecular Immunology, 2010, 47, 1292-1298
2.246Citations (PDF)
458CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials3.71,702Citations (PDF)
459Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes
Lancet, The, 2010, 376, 449-457
62.1214Citations (PDF)
460Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis16.5715Citations (PDF)
461Inpatient rehabilitation specifically designed for geriatric patients: systematic review and meta-analysis of randomised controlled trials
BMJ: British Medical Journal, 2010, 340, c1718-c1718
0.1452Citations (PDF)
462Prioritising prevention strategies for patients in antiretroviral treatment programmes in resource-limited settings1.422Citations (PDF)
463Adjusting Mortality for Loss to Follow-Up: Analysis of Five ART Programmes in Sub-Saharan Africa
PLoS ONE, 2010, 5, e14149
2.393Citations (PDF)
464Body Mass Index and Cancer Risk: The Evidence for Causal Association
The Open Obesity Journal, 2010, 2, 12-22
0.45Citations (PDF)
465Body Mass Index and Cancer Risk: The Evidence for Causal Association~!2009-04-22~!2009-06-16~!2010-07-13~!
The Open Obesity Journal, 2010, 2, 12-22
0.46Citations (PDF)
466Skeletal morphofunctional considerations and the pituitary-thyroid axis1.99Citations (PDF)
467Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis
PLoS ONE, 2009, 4, e5790
2.3430Citations (PDF)
468Efficacy of pneumococcal vaccination in adults: a meta-analysis
Cmaj, 2009, 180, 48-58
1.2357Citations (PDF)
469Cohort Profile: The Swiss National Cohort--a longitudinal study of 6.8 million people4.9158Citations (PDF)
470Annie Darwin's death, the evolution of tuberculosis and the need for systems epidemiology4.915Citations (PDF)
471Role of the polypeptide backbone and post-translational modifications in cross-reactivity of Art v 1, the major mugwort pollen allergen
Biological Chemistry, 2009, 390, 445-451
2.128Citations (PDF)
472Efficacy of pneumococcal polysaccharide vaccine
Cmaj, 2009, 180, 1134-1135
1.27Citations (PDF)
473Routine Vaccination Against Pertussis and the Risk of Childhood Asthma: A Population-Based Cohort Study
Pediatrics, 2009, 123, 944-950
4.529Citations (PDF)
474Mortality of HIV-Infected Patients Starting Antiretroviral Therapy in Sub-Saharan Africa: Comparison with HIV-Unrelated Mortality
PLoS Medicine, 2009, 6, e1000066
8.0169Citations (PDF)
475Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries4.9178Citations (PDF)
476CD4+T Cell Count Decreases by Ethnicity among Untreated Patients with HIV Infection in South Africa and Switzerland
Journal of Infectious Diseases, 2009, 200, 1729-1735
3.730Citations (PDF)
477Variable Impact on Mortality of AIDS‐Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS‐Defining Conditions Are Created Equal
Clinical Infectious Diseases, 2009, 48, 1138-1151
5.2113Citations (PDF)
478Mejorar la comunicación de estudios observacionales en epidemiología (STROBE): explicación y elaboración
Gaceta Sanitaria, 2009, 23, 158.e1-158.e28
1.0168Citations (PDF)
479Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy1.979Citations (PDF)
480Lifestyle factors and colorectal cancer risk (1): systematic review and meta‐analysis of associations with body mass index
Colorectal Disease, 2009, 11, 547-563
2.0176Citations (PDF)
481Temporal and spatial variability of personal exposure to radio frequency electromagnetic fields
Environmental Research, 2009, 109, 779-785
7.7162Citations (PDF)
482Successful Treatment of Severe Acute Intestinal Graft-versus-Host Resistant to Systemic and Topical Steroids with Alemtuzumab1.649Citations (PDF)
483Immune recognition of novel isoforms and domains of the mugwort pollen major allergen Art v 1
Molecular Immunology, 2009, 46, 416-421
2.231Citations (PDF)
484Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studies0.818Citations (PDF)
485Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
Lancet Oncology, The, 2009, 10, 855-864
27.4698Citations (PDF)
486Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
Lancet, The, 2009, 373, 1532-1542
62.1583Citations (PDF)
487Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies
Lancet, The, 2009, 373, 1352-1363
62.1689Citations (PDF)
488When One Depends on the Other
Epidemiology, 2009, 20, 161-166
2.8118Citations (PDF)
489Incidence and Risk Factors of HIV-Related Non-Hodgkin's Lymphoma in the era of Combination Antiretroviral Therapy: A European Multicohort Study
Antiviral Therapy, 2009, 14, 1065-1074
1.9103Citations (PDF)
490Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy
Aids, 2009, 23, 2029-2037
2.567Citations (PDF)
491Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis
Aids, 2009, 23, 1397-1404
2.5862Citations (PDF)
492Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring
Aids, 2009, 23, 1867-1874
2.5142Citations (PDF)
493Das Strengthening the Reporting of Observational Studies in Epidemiology (STROBE-) Statement
Der Internist, 2008, 49, 688-693
0.4198Citations (PDF)
494Das Strengthening the Reporting of Observational Studies in Epidemiology (STROBE-) Statement
Notfall Und Rettungsmedizin, 2008, 11, 260-265
0.974Citations (PDF)
495Reply
Arthritis and Rheumatism, 2008, 58, 1561-1562
6.10Citations (PDF)
496Statistical analysis of personal radiofrequency electromagnetic field measurements with nondetects
Bioelectromagnetics, 2008, 29, 471-478
1.3106Citations (PDF)
497Array‐based profiling of ragweed and mugwort pollen allergens6.796Citations (PDF)
498Antiretroviral therapy in resource‐limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub‐Saharan Africa, Asia and Latin America1.9163Citations (PDF)
499Declaración de la Iniciativa STROBE (Strengthening the Reporting of Observational studies in Epidemiology): directrices para la comunicación de estudios observacionales
Gaceta Sanitaria, 2008, 22, 144-150
1.0387Citations (PDF)
500Graphical presentation of diagnostic information2.544Citations (PDF)
501Cardiovascular mortality and exposure to extremely low frequency magnetic fields: a cohort study of Swiss railway workers5.219Citations (PDF)
502An empirical comparison of methods for meta-analysis of diagnostic accuracy showed hierarchical models are necessary3.7200Citations (PDF)
503The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies3.715,127Citations (PDF)
504Meta-analysis in medical research: Potentials and limitations1.861Citations (PDF)
505Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Lancet, The, 2008, 371, 569-578
62.14,830Citations (PDF)
506Mycobacterium avium subspecies paratuberculosis and Crohn's disease – Authors' reply16.53Citations (PDF)
507Pneumococcal polysaccharide vaccine effectiveness: study quality must not be ignored16.52Citations (PDF)
508Residence Near Power Lines and Mortality From Neurodegenerative Diseases: Longitudinal Study of the Swiss Population3.3118Citations (PDF)
509Preventing HIV in resource-limited settings: evidence for action, from cross-sectional surveys4.90Citations (PDF)
510Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
BMJ: British Medical Journal, 2008, 336, 601-605
0.12,329Citations (PDF)
511Eearly loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries2.0285Citations (PDF)
512Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies2.461Citations (PDF)
513Promotion of health in older people: a randomised controlled trial of health risk appraisal in British general practice
Age and Ageing, 2008, 37, 565-571
1.869Citations (PDF)
514Reply to Colebunders and Caluwaerts
Clinical Infectious Diseases, 2008, 46, 1482-1483
5.20Citations (PDF)
515Childhood leukaemia and socioeconomic status: what is the evidence?
Radiation Protection Dosimetry, 2008, 132, 246-254
0.648Citations (PDF)
516Gender and the Use of Antiretroviral Treatment in Resource-Constrained Settings: Findings from a Multicenter Collaboration
Journal of Women's Health, 2008, 17, 47-55
2.1182Citations (PDF)
517What Do Case-Control Studies Estimate? Survey of Methods and Assumptions in Published Case-Control Research
American Journal of Epidemiology, 2008, 168, 1073-1081
3.3174Citations (PDF)
518Multidimensional Geriatric Assessment: Back to the Future Multidimensional Preventive Home Visit Programs for Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials3.4241Citations (PDF)
519Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?
Aids, 2008, 22, 2481-2492
2.518Citations (PDF)
520Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies
Aids, 2008, 22, 2291-2302
2.5158Citations (PDF)
521Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared
PLoS Medicine, 2008, 5, e148
8.0114Citations (PDF)
522Source of funding and results of studies of health effects of mobile phone use: systematic review of experimental studies
Ciencia E Saude Coletiva, 2008, 13, 1005-1012
0.811Citations (PDF)
523Declaración de la iniciativa STROBE (Strengthening the Reporting of Observational Studies in Epidemiology): directrices para la comunicación de estudios observacionales0.4168Citations (PDF)
524Molecular Properties of Plant Food Allergens: A Current Classification into Protein Families0.238Citations (PDF)
525Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings2.0147Citations (PDF)
526Recombinant Human Erythropoiesis Stimulating Agents in Cancer Patients: Individual Patient Data Meta-Analysis on Behalf of the EPO IPD Meta-Analysis Collaborative Group
Blood, 2008, 112, 4675-4675
4.84Citations (PDF)
527Prognostic Importance of Anaemia in HIV Type-1-Infected Patients Starting Antiretroviral Therapy: Collaborative Analysis of Prospective Cohort Studies
Antiviral Therapy, 2008, 13, 959-967
1.975Citations (PDF)
528Factors Associated with the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study
Clinical Infectious Diseases, 2007, 45, 111-119
5.2249Citations (PDF)
529A unification of models for meta-analysis of diagnostic accuracy studies
Biostatistics, 2007, 8, 239-251
2.1672Citations (PDF)
530Leukaemia, brain tumours and exposure to extremely low frequency magnetic fields: cohort study of Swiss railway employees2.841Citations (PDF)
531The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies*2.01,525Citations (PDF)
532Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
PLoS Medicine, 2007, 4, e297
8.05,250Citations (PDF)
533Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project0.141Citations (PDF)
534Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
BMJ: British Medical Journal, 2007, 335, 806-808
0.19,109Citations (PDF)
535Placebo-controlled trials of Chinese herbal medicine and conventional medicine comparative study4.943Citations (PDF)
536Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review0.1285Citations (PDF)
537A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men4.923Citations (PDF)
538The characteristics of unsolicited clinical oncology literature provided by pharmaceutical industry
Annals of Oncology, 2007, 18, 1580-1582
9.95Citations (PDF)
539Tuberculosis after Initiation of Antiretroviral Therapy in Low-Income and High-Income Countries
Clinical Infectious Diseases, 2007, 45, 1518-1521
5.298Citations (PDF)
540Intravenous magnesium for acute myocardial infarction2.131Citations (PDF)
541Early antiretroviral therapy mortality in resource-limited settings: what can we do about it?3.35Citations (PDF)
542Discordant Responses to Potent Antiretroviral Treatment in Previously Naive HIV-1-Infected Adults Initiating Treatment in Resource-Constrained Countries1.895Citations (PDF)
543Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies
Aids, 2007, 21, 1185-1197
2.5269Citations (PDF)
544The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement
Epidemiology, 2007, 18, 800-804
2.81,883Citations (PDF)
545Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
Epidemiology, 2007, 18, 805-835
2.82,541Citations (PDF)
546The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
Preventive Medicine, 2007, 45, 247-251
2.81,020Citations (PDF)
547Bibliographic study showed improving methodology of meta-analyses published in leading journals 1993–20023.724Citations (PDF)
548Matched-pair study showed higher quality of placebo-controlled trials in Western phytotherapy than conventional medicine
Journal of Clinical Epidemiology, 2007, 60, 787.e1-787.e15
3.718Citations (PDF)
549A review identifies and classifies reasons for ordering diagnostic tests3.768Citations (PDF)
550The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Lancet, The, 2007, 370, 1453-1457
62.117,376Citations (PDF)
551Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis16.5477Citations (PDF)
552Grey literature in meta-analyses of randomized trials of health care interventions2.1377Citations (PDF)
553The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
PLoS Medicine, 2007, 4, e296
8.09,979Citations (PDF)
554Source of Funding and Results of Studies of Health Effects of Mobile Phone Use: Systematic Review of Experimental Studies8.3116Citations (PDF)
555Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: A randomized controlled trial
Arthritis and Rheumatism, 2007, 56, 3610-3619
6.1132Citations (PDF)
556HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy
Journal of Internal Medicine, 2007, 261, 255-267
7.316Citations (PDF)
557Development, feasibility and performance of a health risk appraisal questionnaire for older persons2.5230Citations (PDF)
558Substitutions Due to Antiretroviral Toxicity or Contraindication in the First 3 years of Antiretroviral Therapy in a Large South African Cohort
Antiviral Therapy, 2007, 12, 753-760
1.9119Citations (PDF)
559Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials2.122Citations (PDF)
560Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
Lancet, The, 2006, 367, 817-824
62.11,053Citations (PDF)
561HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis
Lancet, The, 2006, 368, 451-458
62.1214Citations (PDF)
562Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials
American Heart Journal, 2006, 152, 27-38
2.9422Citations (PDF)
563A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints
Statistics in Medicine, 2006, 25, 3443-3457
1.72,027Citations (PDF)
564Pollen‐food syndromes associated with weed pollinosis: an update from the molecular point of view6.7216Citations (PDF)
565Predicting the Risk of Hospital Admission in Older Persons—Validation of a Brief Self-Administered Questionnaire in Three European Countries2.944Citations (PDF)
566Sleepless night, the moon is bright: longitudinal study of lunar phase and sleep
Journal of Sleep Research, 2006, 15, 149-153
3.857Citations (PDF)
567Accuracy of B-Type Natriuretic Peptide Tests to Exclude Congestive Heart Failure8.157Citations (PDF)
568Partner notification of chlamydia infection in primary care: randomised controlled trial and analysis of resource use0.161Citations (PDF)
569Human Metapneumovirus Infection in a Hematopoietic Stem Cell Transplant Recipient with Relapsed Multiple Myeloma and Rapidly Progressing Lung Cancer4.026Citations (PDF)
570Vulvovaginal-Swab or First-Catch Urine Specimen To Detect Chlamydia trachomatis in Women in a Community Setting?4.044Citations (PDF)
571Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review
BMJ: British Medical Journal, 2006, 332, 875-884
0.163Citations (PDF)
572Meta-Analysis: Accuracy of Rapid Tests for Malaria in Travelers Returning from Endemic Areas
Annals of Internal Medicine, 2005, 142, 836-846
9.6145Citations (PDF)
573Response to Highly Active Antiretroviral Therapy at 6 Months and Long-Term Disease Progression in HIV-1 Infection1.833Citations (PDF)
574The Changing Incidence of AIDS Events in Patients Receiving Highly Active Antiretroviral Therapy8.1128Citations (PDF)
575IGF-I, IGF binding protein-3 and breast cancer risk: Comparison of 3 meta-analyses
International Journal of Cancer, 2005, 115, 1006-1007
4.335Citations (PDF)
576Years of life lost attributable to air pollution in Switzerland: dynamic exposure–response model4.937Citations (PDF)
577Antiretroviral therapy in resource-poor settings: scaling up inequalities?4.927Citations (PDF)
578Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts4.972Citations (PDF)
579RE: “QUALITY OF REPORTING OF OBSERVATIONAL LONGITUDINAL RESEARCH”
American Journal of Epidemiology, 2005, 162, 1032-1033
3.31Citations (PDF)
580Mechanisms of improved survival from intensive followup in colorectal cancer: a hypothesis
British Journal of Cancer, 2005, 92, 430-433
5.557Citations (PDF)
581Enhanced Enzyme Immunoassay with Negative-Gray-Zone Testing Compared to a Single Nucleic Acid Amplification Technique for Community-Based Chlamydial Screening of Men4.09Citations (PDF)
582Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study0.1117Citations (PDF)
583Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study
Lancet, The, 2005, 366, 378-384
62.1539Citations (PDF)
584Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy
Lancet, The, 2005, 366, 726-732
62.1777Citations (PDF)
585Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization34.5554Citations (PDF)
586Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data3.722Citations (PDF)
587HIV and male circumcision?a systematic review with assessment of the quality of studies16.5115Citations (PDF)
588Lyme-Borreliose – Übersicht0.11Citations (PDF)
589Die Schweizerische HIV-Kohortenstudie – Ressource für Epidemiologie und Prävention0.12Citations (PDF)
590MDR1Genetic Polymorphism Does Not Modify either Cell Permissiveness to HIV‐1 or Disease Progression before Treatment
Journal of Infectious Diseases, 2004, 189, 583-586
3.722Citations (PDF)
591Authors' response4.90Citations (PDF)
592The correct approach to modelling and evaluating chlamydia screening2.414Citations (PDF)
593Ruling a diagnosis in or out with “SpPIn” and “SnNOut”: a note of caution
BMJ: British Medical Journal, 2004, 329, 209-213
0.1159Citations (PDF)
594Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials0.163Citations (PDF)
595The chlamydia screening studies: rationale and design2.440Citations (PDF)
596A systematic review of the survival and complication rates of fixed partial dentures (FPDs) after an observation period of at least 5 years. I. Implant-supported FPDs4.6457Citations (PDF)
597A systematic review of the survival and complication rates of fixed partial dentures (FPDs) after an observation period of at least 5 years. II. Combined tooth-implant-supported FPDs4.6274Citations (PDF)
598A systematic review of the survival and complication rates of fixed partial dentures (FPDs) after an observation period of at least 5 years. IV. Cantilever or extension FPDs4.6279Citations (PDF)
599Commentary II - The journal impact factor in the evaluation of research quality: villain, scapegoat or innocent bystander?0.014Citations (PDF)
600Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy
Statistics in Medicine, 2004, 23, 2375-2398
1.754Citations (PDF)
601Risk factors for asymptomatic abdominal aortic aneurysm: Systematic review and meta-analysis of population-based screening studies0.3259Citations (PDF)
602How strong is the evidence that illicit drug use by young people is an important cause of psychological or social harm? methodological and policy implications of a systematic review of longitudinal, general population studies1.214Citations (PDF)
603Antiretroviral Treatment and Osteonecrosis in Patients of the Swiss HIV Cohort Study: A Nested Case-Control Study1.428Citations (PDF)
604Subgroup analyses in randomized trials: risks of subgroup-specific analyses;3.7717Citations (PDF)
605Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
Lancet, The, 2004, 363, 1346-1353
62.11,616Citations (PDF)
606Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies
Lancet, The, 2004, 363, 1579-1588
62.1605Citations (PDF)
607Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
Lancet, The, 2004, 364, 2021-2029
62.1847Citations (PDF)
608Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population
Lancet, The, 2003, 362, 877-878
62.1102Citations (PDF)
609Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer3.753Citations (PDF)
610Women’s perception of the benefits of mammography screening: population-based survey in four countries4.9188Citations (PDF)
611CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 YearsThe Swiss HIV Cohort Study8.1360Citations (PDF)
612Efficacy of Virosome Hepatitis A Vaccine in Young Children in Nicaragua: Randomized Placebo‐Controlled Trial
Journal of Infectious Diseases, 2003, 188, 671-677
3.769Citations (PDF)
613New quinolones for the treatment of community-acquired pneumonia - contra0.20Citations (PDF)
614Antibodies to Chlamydia trachomatis Heat-Shock Protein 60 kDa and Detection of Mycoplasma genitalium and Ureaplasma urealyticum Are Associated Independently With Chronic Nongonococcal Urethritis1.214Citations (PDF)
615Parametric survival models may be more accurate than Kaplan-Meier estimates
BMJ: British Medical Journal, 2003, 326, 822-822
0.110Citations (PDF)
616Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials
BMJ: British Medical Journal, 2002, 324, 813-813
0.1594Citations (PDF)
617Studies of the social causes of tuberculosis in Germany before the First World War: extracts from Mosse and Tugendreich’s landmark book4.92Citations (PDF)
618What should we do about screening for genital chlamydia?4.936Citations (PDF)
619Home Visits to Prevent Nursing Home Admission and Functional Decline in Elderly People16.5555Citations (PDF)
620Where now for meta-analysis?4.9156Citations (PDF)
621What is newsworthy? Longitudinal study of the reporting of medical research in two British newspapers0.1187Citations (PDF)
622A Controlled Trial of Geriatric Evaluation34.516Citations (PDF)
623Direction and impact of language bias in meta-analyses of controlled trials: empirical study4.9832Citations (PDF)
624Do all men attending departments of genitourinary medicine need to be screened for non-gonococcal urethritis?1.262Citations (PDF)
625Quality of Reporting of Randomized Trials as a Measure of Methodologic Quality16.5355Citations (PDF)
626Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
Lancet, The, 2002, 360, 119-129
62.11,443Citations (PDF)
627A placebo-controlled randomized trial of eradication of Helicobacter pylori in the general population:
Contemporary Clinical Trials, 2002, 23, 321-332
2.831Citations (PDF)
628Statistical methods for assessing the influence of study characteristics on treatment effects in ‘meta-epidemiological’ research
Statistics in Medicine, 2002, 21, 1513-1524
1.7335Citations (PDF)
629The CONSORT Statement: Explanation and Elaboration
Annals of Internal Medicine, 2002, 136, 926-927
9.60Citations (PDF)
630Systematic reviews in health care: Assessing the quality of controlled clinical trials0.12,885Citations (PDF)
631Funnel plots for detecting bias in meta-analysis3.73,526Citations (PDF)
632Early enteral feeding versus "nil by mouth" after gastrointestinal surgery: systematic review and meta-analysis of controlled trials
BMJ: British Medical Journal, 2001, 323, 773-773
0.1748Citations (PDF)
633Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study
Aids, 2001, 15, 501-507
2.528Citations (PDF)
634Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis
BMJ: British Medical Journal, 2001, 323, 101-105
0.12,013Citations (PDF)
635Increased risk of wasting syndrome in HIV-infected travellers: prospective multicentre study1.320Citations (PDF)
636Helicobacter sp. Flexispira Bacteremia in an Immunocompetent Young Adult4.019Citations (PDF)
637Highly active antiretroviral therapy and coronary heart disease: the need for perspective
Aids, 2001, 15, S193-S201
2.526Citations (PDF)
638Hyperlactatemia and Antiretroviral Therapy: The Swiss HIV Cohort Study
Clinical Infectious Diseases, 2001, 33, 1931-1937
5.2222Citations (PDF)
639Role of Mycoplasma genitalium and Ureaplasma urealyticum in Acute and Chronic Nongonococcal Urethritis
Clinical Infectious Diseases, 2001, 32, 995-1003
5.2172Citations (PDF)
640Uses and abuses of meta-analysis
Clinical Medicine, 2001, 1, 478-484
1.3247Citations (PDF)
641Effectiveness of home based support for older people: systematic review and meta-analysis Commentary: When, where, and why do preventive home visits
BMJ: British Medical Journal, 2001, 323, 719-719
0.1407Citations (PDF)
642Are randomised controlled trials in the BMJ different?
BMJ: British Medical Journal, 2001, 323, 1253.2
0.151Citations (PDF)
643Circumcision in men and the prevention of HIV infection: a 'meta-analysis' revisited1.277Citations (PDF)
644Epidemiology and the World Wide Web: Is There a 'Net Benefit?
Epidemiologic Reviews, 2000, 22, 181-185
2.15Citations (PDF)
645Effect of Antiretroviral Therapy on Viral Load, CD4 Cell Count, and Progression to Acquired Immunodeficiency Syndrome in a Community Human Immunodeficiency Virus–Infected Cohort8.161Citations (PDF)
646Publication and related bias in meta-analysis3.72,125Citations (PDF)
647Promotion of condom use in a high-risk setting in Nicaragua: a randomised controlled trial
Lancet, The, 2000, 355, 2101-2105
62.182Citations (PDF)
648Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis
Lancet, The, 2000, 355, 2217-2218
62.169Citations (PDF)
649Infections in pregnancy0.12Citations (PDF)
650Discontinuation of Primary Prophylaxis againstPneumocystis cariniiPneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy
New England Journal of Medicine, 1999, 340, 1301-1306
34.5277Citations (PDF)
651The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis16.51,767Citations (PDF)
652AIDS-Related Opportunistic Illnesses Occurring After Initiation of Potent Antiretroviral Therapy16.5427Citations (PDF)
653Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study0.1210Citations (PDF)
654Fruit and vegetables and ischaemic heart disease: systematic review or misleading meta-analysis?2.519Citations (PDF)
655Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
Lancet, The, 1999, 353, 863-868
62.1899Citations (PDF)
656Triglyceride as a risk factor for ischaemic heart disease in British men: effect of adjusting for measurement error
Atherosclerosis, 1999, 143, 275-284
1.540Citations (PDF)
657Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study
Aids, 1999, 13, 2547-2554
2.569Citations (PDF)
658Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials
Aids, 1999, 13, 2075-2082
2.5123Citations (PDF)
659Meta-analyses of observational data should be done with due care0.121Citations (PDF)
660Role of antioxidant vitamins in prevention of cardiovascular diseases
BMJ: British Medical Journal, 1999, 319, 577-577
0.122Citations (PDF)
661Incommunicable Knowledge? Interpreting and Applying the Results of Clinical Trials and Meta-Analyses3.753Citations (PDF)
662Impact of antiretroviral combination therapies on AIDS surveillance reports in Switzerland
Aids, 1998, 12, 1195-1201
2.542Citations (PDF)
663Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis
BMJ: British Medical Journal, 1998, 316, 1776-1780
0.1177Citations (PDF)
664Reporting on quality of life in randomised controlled trials: bibliographic study
BMJ: British Medical Journal, 1998, 317, 1191-1194
0.1264Citations (PDF)
665Does Pregnancy Influence the Course of HIV Infection?0.359Citations (PDF)
666meta-analysis bias in location and selection of studies0.11,249Citations (PDF)
667Meta-analysis Spurious precision? Meta-analysis of observational studies
BMJ: British Medical Journal, 1998, 316, 140-144
0.1891Citations (PDF)
668Meta-analysis: Unresolved issues and future developments
BMJ: British Medical Journal, 1998, 316, 221-225
0.1153Citations (PDF)
669Disseminated Mycobacterium avium complex disease in the Swiss HIV Cohort Study
Aids, 1997, 11, 1165-1171
2.527Citations (PDF)
670Peripheral autonomic nerve dysfunction in asymptomatic leprosy contacts2.120Citations (PDF)
671Quantification and the quest for medical certainty3.70Citations (PDF)
672Language bias in randomised controlled trials published in English and German
Lancet, The, 1997, 350, 326-329
62.11,030Citations (PDF)
673Changes in population distribution of sense of coherence do not explain changes in overall mortality0.15Citations (PDF)
674Bias in meta-analysis detected by a simple, graphical test
BMJ: British Medical Journal, 1997, 315, 629-634
0.151,349Citations (PDF)
675Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
BMJ: British Medical Journal, 1997, 315, 1194-1199
0.1542Citations (PDF)
676Personal paper: Disclosure of clinical audit records in law: risks and possible defences
BMJ: British Medical Journal, 1997, 315, 1369-1370
0.14Citations (PDF)
677Meta-analysis: Potentials and promise
BMJ: British Medical Journal, 1997, 315, 1371-1374
0.1524Citations (PDF)
678Meta-analysis: Principles and procedures
BMJ: British Medical Journal, 1997, 315, 1533-1537
0.11,953Citations (PDF)
679Meta-analysis: Beyond the grand mean?
BMJ: British Medical Journal, 1997, 315, 1610-1614
0.1148Citations (PDF)
680Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial
Vaccine, 1996, 14, 982-986
3.191Citations (PDF)
681A controlled HIV/AIDS-related health education programme in Managua, Nicaragua
Aids, 1996, 10, 537-544
2.531Citations (PDF)
682Genital chlamydial infection among women in Nicaragua: validity of direct fluorescent antibody testing, prevalence, risk factors and clinical manifestations.2.47Citations (PDF)
683The CONSORT Statement16.513Citations (PDF)
684Smoking and health promotion in Nazi Germany.2.93Citations (PDF)
685Vasomotor reflex testing in leprosy patients, healthy contacts and controls: a cross-sectional study in Western Nepal
Leprosy Review, 1996, 67,
0.516Citations (PDF)
686Hepatitis A vaccine3.37Citations (PDF)
687Genital Chlamydia trachomatis Infections in Uppsala County, Sweden, 1985–19931.263Citations (PDF)
688Smoking and death0.117Citations (PDF)
689Differences in progression of HIV infection between men and women0.16Citations (PDF)
690Misleading meta-analysis
BMJ: British Medical Journal, 1995, 311, 753.4-754
0.1112Citations (PDF)
691Smoking and health promotion in Nazi Germany.2.952Citations (PDF)
692The Swiss HIV Cohort Study: Rationale, organization and selected baseline characteristics0.0139Citations (PDF)
693Thyroid cancer in Belarus post-Chernobyl: Improved detection or increased incidence?0.039Citations (PDF)
694Cotrimoxazol in the Treatment of Mycobacterium Ulcerans Infection (Buruli Ulcer) in West Africa
Tropical Doctor, 1994, 24, 61-63
0.427Citations (PDF)
695Survival in HIV infection: do sex and category of transmission matter?
Aids, 1994, 8, 1307-1313
2.549Citations (PDF)
696Fallout from Chernobyl Thyroid cancer in children increased dramatically in Belarus
BMJ: British Medical Journal, 1994, 309, 1298-1301
0.119Citations (PDF)
697Cholesterol Reduction and Stroke
Annals of Internal Medicine, 1994, 120, 88-89
9.61Citations (PDF)
698Making sense of meta-analysis1.95Citations (PDF)
699Childhood anemia in Africa: To transfuse or not transfuse?
Acta Tropica, 1993, 55, 47-51
2.252Citations (PDF)
700Socioeconomic differentials in wealth and health.
BMJ: British Medical Journal, 1993, 307, 1085-1086
0.176Citations (PDF)
701Aids in Nicaragua: Epidemiological, Political, and Sociocultural Perspectives1.717Citations (PDF)
702Hypoglycaemia with human and porcine insulins.
BMJ: British Medical Journal, 1993, 306, 719.4-720
0.11Citations (PDF)
703Human insulin and unawareness of hypoglycaemia: need for a large randomised trial.
BMJ: British Medical Journal, 1992, 305, 351-355
0.118Citations (PDF)
704Human Versus Porcine Insulin Gone Wrong
Diabetes Care, 1992, 15, 585-586
6.24Citations (PDF)
705Post-Challenge Glucose Concentration, Impaired Glucose Tolerance, Diabetes, and Cancer Mortality in Men
American Journal of Epidemiology, 1992, 136, 1110-1114
3.3108Citations (PDF)
706Risk of severe hypoglycaemia in insulin treated diabetic patients transferred to human insulin: a case control study.
BMJ: British Medical Journal, 1991, 303, 617-621
0.145Citations (PDF)
707Influence of human insulin on symptoms and awareness of hypoglycaemia: a randomised double blind crossover trial.
BMJ: British Medical Journal, 1991, 303, 622-626
0.154Citations (PDF)
708Human Insulin and Hypoglycaemia Unawareness: Insights from Pittsburgh?
Diabetic Medicine, 1991, 8, 885-886
2.92Citations (PDF)
709Increasing Incidence of Hypoglycemic Coma in Children With IDDM
Diabetes Care, 1991, 14, 1001-1005
6.249Citations (PDF)
710Symptomatic Awareness of Hypoglycaemia: Does it Change on Transfer from Animal to Human Insulin?
Diabetic Medicine, 1990, 7, 269-269
2.913Citations (PDF)
711Symptoms and transmission of intestinal cryptosporidiosis.2.336Citations (PDF)
712Diabetes and Hypertension8.154Citations (PDF)
713Re: Hypoglycaemia (un)awareness: human vs animal insulin
Diabetologia, 1988, 31, 453-454
7.57Citations (PDF)
714Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data2.1104Citations (PDF)
715Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old2.115Citations (PDF)
716Occurrence of relapsing polychondritis with a rising cANCA titre in a cANCA-positive systemic and cerebral vasculitis patient
BMJ Case Reports, 0, 2013, bcr-2013-008717
0.47Citations (PDF)
717Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis
ELife, 0, 6,
0.720Citations (PDF)
718Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study0.188Citations (PDF)
719Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration
BMJ, The, 0, , n2233
0.21,323Citations (PDF)
720Cervical cancer in women living in South Africa: a record linkage study of the National Health Laboratory Service and the National Cancer Registry0.912Citations (PDF)
721The effect of combining antibiotics on resistance: A systematic review and meta-analysis
ELife, 0, 13,
0.72Citations (PDF)
722Developing clinical prediction models: a step-by-step guide
BMJ, The, 0, 386, e078276
0.2331Citations (PDF)
723The effect of combining antibiotics on resistance: A systematic review and meta-analysis
ELife, 0, 13,
0.76Citations (PDF)
724HIV-1 Viremia and Cancer Risk in 2.8 Million People: The South African HIV Cancer Match Study5.25Citations (PDF)
725Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral Therapy in Sub-Saharan Africa: The DTG RESIST Study5.211Citations (PDF)
726Anal Cancer Incidence Rates Among Men and Women With and Without HIV in South Africa0.81Citations (PDF)
727A supervised machine learning approach for assessing grant peer review reports2.75Citations (PDF)
728Incidence and prognostic factors of self-harm and subsequent unnatural death in South Africa: A cohort study
PLoS Medicine, 0, 22, e1004765
8.04Citations (PDF)
729Immunodeficiency, HIV Viremia, and Incident Anal Cancer Among People With HIV in South Africa0.80Citations (PDF)
730Meta-Analysen0.00Citations (PDF)
731Linkage of HIV treatment and population-based surveillance records in rural South Africa: the AHRI Unified Data Platform (AUDP)2.60Citations (PDF)
732Association of Immunodeficiency and HIV Viremia With Cervical Precancer and Cancer Risk Among Women With HIV in South Africa5.20Citations (PDF)